FRANKLIN, Tenn., Feb. 16, 2011 /PRNewswire/ -- Georgia Health Sciences University presented a poster at the recent 11th National Conference on Cancer Nursing Research in Los Angeles, in which their clinical study showed that RyMed Technologies' InVision-Plus® IV Connector significantly decreased venous catheter occlusions in patients from both outpatient and inpatient cancer clinical settings. The study compared one simple split septum negative displacement IV connector (Becton-Dickinson Q-Syte®) against a zero fluid displacement connector (RyMed's InVision-Plus® IV Connector).
Venous access catheters and needleless IV connectors are a necessary part of cancer patient treatment. Thrombotic occlusions, which are blood clots within the catheter lumen, are a significant complication of vascular access catheters and IV connectors that can lead in some instances to a partial or totally occluded catheter and potentially lead to biofilm development and deadly bloodstream infections.
Dr. Cynthia C. Chernecky PhD, RN, AOCN, FAAN at Georgia Health Sciences University was the lead presenter of the clinical poster. The overall reductions in occlusion rates were significant with the InVision-Plus® IV Connector. The pediatric outpatient population saw a 93% reduction in occlusions. This is particularly significant since the primary care for this group of patients is the parent or the clinical personnel where the patient lives. The zero fluid displacement connector averaged a 73% reduction in occlusion rates versus the split septum negative displacement IV connector in the three departments evaluated; ICU, inpatient and outpatient populations.
Dr. Chernecky stated, "The preventio
|SOURCE RyMed Technologies, Inc.|
Copyright©2010 PR Newswire.
All rights reserved